A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists.

Autor: Cotes RO; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 10 Park Place, Suite 620, Atlanta, GA, 30303, USA. robert.o.cotes@emory.edu., Janjua AU; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 10 Park Place, Suite 620, Atlanta, GA, 30303, USA., Broussard B; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 10 Park Place, Suite 620, Atlanta, GA, 30303, USA., Lazris D; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 10 Park Place, Suite 620, Atlanta, GA, 30303, USA., Khan A; School of Medicine, American University of Integrative Sciences, Bridgetown, Barbados., Jiao Y; Emory University Rollins School of Public Health, Atlanta, GA, USA., Kopelovich SL; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA., Goldsmith DR; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 10 Park Place, Suite 620, Atlanta, GA, 30303, USA.
Jazyk: angličtina
Zdroj: Community mental health journal [Community Ment Health J] 2022 Apr; Vol. 58 (3), pp. 517-525. Date of Electronic Publication: 2021 May 29.
DOI: 10.1007/s10597-021-00847-0
Abstrakt: Considerable variation in clozapine utilization exists across the United States, and little is known about the perspective of psychiatrists in states with low clozapine use. To better understand clozapine practices, attitudes, and barriers, a survey was administered to a group of southeastern state conference attendees (SSCA; N = 86). The same survey was administered to psychiatrists belonging to a national community psychiatry organization (AACP; N = 57), and differences were analyzed across the two samples. In comparison to the AACP, the SSCA group felt less comfortable, perceived clozapine as less safe and effective, had fewer patients on clozapine, and were more likely to prefer antipsychotic polypharmacy to clozapine use. Across the sample, use of a myocarditis screening protocol was rare (N = 14/76; 18%) and less than half used plasma antipsychotic levels to guide dosage (N = 60/129; 47%). Continuing professional education on clozapine are needed for psychiatrists who see individuals with psychotic disorders.
(© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: